Health and Healthcare

Bristol Myers Squibb : BMY

All Bristol Myers Squibb Articles

592 Articles

Lee Jackson | Sep 3, 2014 at 10:45 AM EDT

Credit Suisse’s 4 Top Pharmaceutical Stocks to Buy for the Rest of 2014

A new report from the pharmaceutical team at Credit Suisse highlights four top stocks to buy for the remainder of…

Chris Lange | Aug 21, 2014 at 2:44 PM EDT

ELIQUIS Approved for Deep Vein Thrombosis and Pulmonary Embolisms

ThinkstockBristol-Myers Squibb Company (NYSE: BMY) and Pfizer Inc. (NYSE: PFE) announced that the U.S. Food and Drug Administration (FDA) had…

Jon C. Ogg | Jul 2, 2014 at 8:50 AM EDT

Top Analyst Upgrades and Downgrades: Alcatel-Lucent, Apple, FireEye, JDSU Uniphase, Solar Stocks and More

These are the top analyst upgrades, downgrades and initiations from Wall Street firms for Tuesday, July 2, 2014. They include…

Trey Thoelcke | Jun 11, 2014 at 10:15 AM EDT

Upcoming Binary Events Could Lift These Health Care Stocks Much Higher

In a new report, the analysts at health care boutique Leerink highlight numerous upcoming catalysts for some top stocks in…

Jon C. Ogg | Jun 5, 2014 at 8:30 AM EDT

Top Analyst Upgrades and Downgrades: Apple, Lululemon, Microsoft, NBG, Twitter, Whole Foods and More

These are the top Wall Street analyst upgrades, downgrades and initiations for Thursday, June 5, 2014. They include Apple, Lululemon,…

Trey Thoelcke | May 22, 2014 at 8:20 AM EDT

Why You Buy Big Pharma If the Market Crashes

A new report from the global equity strategy team at Credit Suisse maintains that the best defensive sector now is…

Jon C. Ogg | May 15, 2014 at 8:40 AM EDT

Top Analyst Upgrades and Downgrades: Cisco, Kinder Morgan, Rackspace, Twitter and More

These are the top Wall Street analyst upgrades, downgrades and initiations seen on Thursday, May 15, 2014. They include Cisco…

Trey Thoelcke | Apr 21, 2014 at 9:05 AM EDT

J.P. Morgan’s Top Biotech and Health Care Picks With Huge Upside

In a new research report, the J.P. Morgan health care team highlights their top names to buy after the sell-off…

Trey Thoelcke | Mar 26, 2014 at 8:45 AM EDT

J.P. Morgan Says Buy Specialty and Big Pharmaceuticals Now

Wikimedia CommonsWith the U.S. pharmaceutical group, and particularly the specialty pharmaceutical names, under pressure over recent trading sessions, the large…

Trey Thoelcke | Mar 10, 2014 at 9:05 AM EDT

Four Upcoming Catalysts That Could Move Pharmaceutical Stocks

In a new research report, Cowen analysts posted a list of some of the top new datapoints cited at the…

cgblaine22 | Feb 11, 2014 at 11:15 AM EST

Mallinckrodt May Have to Pay More for Cadence

Cadence Pharmaceuticals agreed Tuesday to be bought out by Mallinckrodt for $1.3 billion, or a more than 27% premium to…

Trey Thoelcke | Jan 29, 2014 at 8:50 AM EST

The Best of the Best Picks of the Credit Suisse Top 50 Stocks

Frank Golhen, via Wikimedia CommonsMost of the firms that we cover on Wall Street have presented their high conviction stock…

Trey Thoelcke | Nov 11, 2013 at 7:30 AM EST

Shire, Novartis Deals: Pharmaceutical Shakeups Continue

ThinkstockThe wave of mergers and acquisitions in health care continues with two big announcements Monday. Drug maker Shire PLC (NASDAQ:…

Jon C. Ogg | Oct 28, 2013 at 8:00 AM EDT

Top Analyst Upgrades and Downgrades: ARM, Crocs, GE, NOV and More

Jon OggEarnings season is in full swing and equities are challenging new highs almost daily. Traders and investors are looking…

Jon C. Ogg | Oct 9, 2013 at 8:15 AM EDT

Credit Suisse Major Drug Stocks to Buy for Great Gains Ahead

ThinkstockThe drug and pharmaceutical sector is supposed to be a defensive one by nature, even if this week’s government shutdown…

1 … 27 28 29 30 31 … 40

Bristol Myers Squibb : BMY

All Bristol Myers Squibb Articles

Credit Suisse’s 4 Top Pharmaceutical Stocks to Buy for the Rest of 2014

ELIQUIS Approved for Deep Vein Thrombosis and Pulmonary Embolisms

Top Analyst Upgrades and Downgrades: Alcatel-Lucent, Apple, FireEye, JDSU Uniphase, Solar Stocks and More

Upcoming Binary Events Could Lift These Health Care Stocks Much Higher

Top Analyst Upgrades and Downgrades: Apple, Lululemon, Microsoft, NBG, Twitter, Whole Foods and More

Why You Buy Big Pharma If the Market Crashes

Top Analyst Upgrades and Downgrades: Cisco, Kinder Morgan, Rackspace, Twitter and More

J.P. Morgan’s Top Biotech and Health Care Picks With Huge Upside

J.P. Morgan Says Buy Specialty and Big Pharmaceuticals Now

Four Upcoming Catalysts That Could Move Pharmaceutical Stocks

Mallinckrodt May Have to Pay More for Cadence

The Best of the Best Picks of the Credit Suisse Top 50 Stocks

Shire, Novartis Deals: Pharmaceutical Shakeups Continue

Top Analyst Upgrades and Downgrades: ARM, Crocs, GE, NOV and More

Credit Suisse Major Drug Stocks to Buy for Great Gains Ahead

XOP vs. OIH: Do Drillers or Service Providers Best Ride Crude Above $100?

A 52-Year-Old With $1.2 Million in a 401(k) Can Access $40,000 Annually Penalty-Free at 57 Using This Strategy

America’s Debt Just Crossed a Level It Hasn’t Hit Since 1946, and Households Are Next in Line

A 52-Year-Old With $1.2 Million in a 401(k) Can Access $40,000 Annually Penalty-Free at 57 Using This Strategy

America's Debt Just Crossed a Level It Hasn't Hit Since 1946, and Households Are Next in Line

XOP vs. OIH: Do Drillers or Service Providers Best Ride Crude Above $100?

A 52-Year-Old With $1.2 Million in a 401(k) Can Access $40,000 Annually Penalty-Free at 57 Using This Strategy

Bristol Myers Squibb : BMY

All Bristol Myers Squibb Articles

Credit Suisse’s 4 Top Pharmaceutical Stocks to Buy for the Rest of 2014

ELIQUIS Approved for Deep Vein Thrombosis and Pulmonary Embolisms

Top Analyst Upgrades and Downgrades: Alcatel-Lucent, Apple, FireEye, JDSU Uniphase, Solar Stocks and More

Upcoming Binary Events Could Lift These Health Care Stocks Much Higher

Top Analyst Upgrades and Downgrades: Apple, Lululemon, Microsoft, NBG, Twitter, Whole Foods and More

Why You Buy Big Pharma If the Market Crashes

Top Analyst Upgrades and Downgrades: Cisco, Kinder Morgan, Rackspace, Twitter and More

J.P. Morgan’s Top Biotech and Health Care Picks With Huge Upside

J.P. Morgan Says Buy Specialty and Big Pharmaceuticals Now

Four Upcoming Catalysts That Could Move Pharmaceutical Stocks

Mallinckrodt May Have to Pay More for Cadence

The Best of the Best Picks of the Credit Suisse Top 50 Stocks

Shire, Novartis Deals: Pharmaceutical Shakeups Continue

Top Analyst Upgrades and Downgrades: ARM, Crocs, GE, NOV and More

Credit Suisse Major Drug Stocks to Buy for Great Gains Ahead

XOP vs. OIH: Do Drillers or Service Providers Best Ride Crude Above $100?

A 52-Year-Old With $1.2 Million in a 401(k) Can Access $40,000 Annually Penalty-Free at 57 Using This Strategy

America’s Debt Just Crossed a Level It Hasn’t Hit Since 1946, and Households Are Next in Line

Featured Reads

A 52-Year-Old With $1.2 Million in a 401(k) Can Access $40,000 Annually Penalty-Free at 57 Using This Strategy

America's Debt Just Crossed a Level It Hasn't Hit Since 1946, and Households Are Next in Line